(1) Novellino MM, Sesma N, Zanardi PR, Laganá DC. Resonance frequency analysis of dental implants placed at the posterior maxilla varying the surface treatment only: A randomized clinical trial. Clin Implant Dent Relat Res. 2017 Jun 20. doi: 10.1111/cid.12510. [Pubblicazione elettronica prima della stampa]
(2) Sartoretto SC, Alves AT, Resende RF, et al. Early osseointegration driven by the surface chemistry and wettability of dental implants. J Appl Oral Sci. 2015 May-Jun;23(3):279-87.
(3) Sartoretto SC, Alves AT, Zarranz L, et al. Hydrophilic surface of Ti6Al4V-ELI alloy improves the early bone apposition of sheep tibia. Clin Oral Implants Res. 2016 Jun 17. doi: 10.1111/clr.12894. [Pubblicazione elettronica prima della stampa]
(4) Val JE, Gómez-Moreno G, Ruiz-Linares M, et al. Effects of Surface Treatment Modification and Implant Design in Implants Placed Crestal and Subcrestally Applying Delayed Loading Protocol. J Craniofac Surg. 2017 Mar;28(2):552-558.
(5) Al-Nsorr MM, Chan HL, Wang HL. Effect of the platform- switching technique on preservation of peri-implant marginal bone: a systematic review. Int J Oral Maxillofac Implants. 2012 Jan-Feb;27(1):138-45.
(6) Annibali S, Bignozzi I, Cristalli MP, et al. Peri-implant marginal bone level: a systematic review and meta-analysis of studies comparing platform switching versus conventionally restored implants. J Clin Periodontol. 2012 Nov;39(11):1097-113.
(7) Hsu YT, Lin GH, Wang HL. Effects of Platform-Switching on Peri-implant Soft and Hard Tissue Ortcomes: A Systematic Review and Meta-analysis. Int J Oral Maxillofac Implants.2017;32(1):e9-e24.
(8) Lazzara RJ, Porter SS. Platform switching: a new concept in implant dentistry for controlling postrestorative crestal bone levels. Int J Periodontics Restorative Dentistry. 2006 Feb;26(1):9-17.
(9) Rocha S, Wagner W, Wiltfang J, Nicolau P, Moergel M, Messias A, Behrens E, Guerra F. Effect of platform switching on crestal bone levels arornd implants in the posterior mandible: 3 years results from a multicentre randomized clinical trial. J Clin Periodontol. 2016 Apr;43(4):374-82.

CEREC è un marchio commerciale o un marchio commerciale registrato di Sirona Dental Systems GmbH.
Dentsply Sirona è un marchio commerciale o un marchio commerciale registrato di Dentsply Sirona Inc.
Medentika è un marchio commerciale o un marchio commerciale registrato di Medentika GmbH.
Panavia è un marchio commerciale o un marchio commerciale registrato di Kuraray Co. Ltd.
Neodent; Grand Morse; Helix GM; Drive GM; Titamax GM; Helix; Drive; Titamax sono marchi commerciali o marchi commerciali registrati di JJGC Indústria e Comércio de Materiais Dentários S.A.